Clinical Trial Update: Tdap Vaccine Safety for Plasma Donors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating safety of Tdap vaccine for plasma donors; results posted with completion in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: GCAM Inc. | Conditions: Tetanus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-12-06